Inflammatory bowel disease: Genetic or environmental diseases?

被引:8
|
作者
Cortot, A. [1 ,2 ]
de Chambrun, G. Pineton [1 ]
Vernier-Massouille, G. [1 ,2 ]
Vigneron, B. [1 ]
Rousseau, C. Gower [2 ]
机构
[1] CHU Lille, Hop Claude Huriez, Serv Hepatogastroenterol, F-59800 Lille, France
[2] CHU Lille, Hop Calmette, INSERM,Serv Epidemiol, InVS,Registre Malad Inflammatoires Chron Intestin, F-59000 Lille, France
来源
关键词
GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; RISK-FACTORS; SUSCEPTIBILITY LOCI; ILEAL MUCOSA; MODERN LIFE; POPULATION; EPIDEMIOLOGY; APPENDECTOMY;
D O I
10.1016/j.gcb.2009.07.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pathophysiology of inflammatory bowel diseases depends on the interaction between genetic susceptibility and environmental factors leading to a deregulated immune intestinal response resulting in bowel lesions. Epidemiologic variations of inflammatory bowel diseases with time (incidence, prevalence) and space suggest a role for risk environmental factors, but so far only smoking habits and appendectomy have been identified as influencing the risk of occurrence and the course of the diseases. Studies of monozygotic and dizygotic twins and the existence of familial aggregation are strong evidence for an important, but not exclusive, role for genetic susceptibility. Since the discovery of NOD2/CARD15 mutations, numerous genes have been associated with inflammatory bowel diseases, some of them involved in the regulation of innate immunity and cellular clearance of infectious agents (autophagy). Thus, new hypothesis include a key role of mucosal human microbiota which could be partly influenced by environmental factors generated by modern life. The improvement of life hygiene, the change of food composition and habits, the industrial pollution in developed countries, may influence, directly or by the way of modifying intestinal human microbiota, inflammatory bowel diseases risk occurrence. (C) 2009 Published by Elsevier Masson SAS.
引用
收藏
页码:681 / 691
页数:11
相关论文
共 50 条
  • [41] Prediction of disease course in inflammatory bowel diseases
    Peter Laszlo Lakatos
    World Journal of Gastroenterology, 2010, 16 (21) : 2589 - 2590
  • [42] Inflammatory Bowel Disease: One or Two Diseases?
    David B. Sachar
    Aaron Walfish
    Current Gastroenterology Reports, 2013, 15 (1)
  • [43] Inflammatory bowel diseases, celiac disease, and bone
    Bianchi, Maria Luisa
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 503 (01) : 54 - 65
  • [44] The genetic burden of inflammatory bowel diseases: implications for the clinic?
    Gabbani, Tommaso
    Deiana, Simona
    Annese, Antonio Luca
    Lunardi, Sarah
    Annese, Vito
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (10) : 1109 - 1117
  • [45] Is the disease course predictable in inflammatory bowel diseases?
    Peter Laszlo Lakatos
    Lajos S Kiss
    World Journal of Gastroenterology, 2010, 16 (21) : 2591 - 2599
  • [46] Inflammatory Bowel Diseases and Parkinson's Disease
    Brudek, Tomasz
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 : S331 - S344
  • [47] Inflammatory Bowel Disease and the Risk of Autoimmune Diseases
    Wilson, J. Claire
    Furlano, Raoul I.
    Jick, Susan S.
    Meier, Christoph R.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (02): : 186 - 193
  • [48] Prediction of disease course in inflammatory bowel diseases
    Lakatos, Peter Laszlo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (21) : 2589 - 2590
  • [49] Is the disease course predictable in inflammatory bowel diseases?
    Lakatos, Peter Laszlo
    Kiss, Lajos S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (21) : 2591 - 2599
  • [50] DISEASE PERCEPTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Yaltonskiy, V. M.
    Sirota, N. A.
    Knyazev, O. V.
    Babayan, A. F.
    Ogarev, V. V.
    Kanatbek, A.
    Tripolskaya, M. D.
    Bodunova, N. A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (02): : 323 - 324